Astellas Pharma Cash on Hand 2012-2025 | ALPMY

Astellas Pharma cash on hand from 2012 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Astellas Pharma Annual Cash on Hand
(Millions of US $)
2024 $2,414
2023 $2,982
2022 $2,765
2021 $2,988
2020 $3,008
2019 $2,825
2018 $3,258
2017 $3,165
2016 $3,108
2015 $4,153
2014 $4,144
2013 $3,326
2012 $3,648
2011
Astellas Pharma Quarterly Cash on Hand
(Millions of US $)
2025-06-30 $1,747
2024-06-30 $2,167
2023-06-30 $4,401
2022-06-30 $2,593
2021-06-30 $2,785
2020-06-30 $2,274
2019-06-30 $2,397
2018-06-30 $3,068
2017-06-30 $3,119
2016-09-30 $3,707
2016-06-30 $3,020
2016-03-31 $3,108
2015-12-31 $2,970
2015-09-30 $3,419
2015-06-30 $3,409
2015-03-31 $4,153
2014-12-31 $4,186
2014-09-30 $4,450
2014-06-30 $3,981
2014-03-31 $4,144
2013-12-31 $3,698
2013-09-30 $3,514
2013-06-30 $3,235
2013-03-31 $3,326
2012-12-31 $3,488
2012-09-30 $3,271
2012-06-30 $3,256
2012-03-31 $3,648
2011-12-31 $3,630
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $12.558B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.303B 32.40
Zoetis (ZTS) United States $54.932B 19.66
Takeda Pharmaceutical (TAK) Japan $51.421B 10.49
Daiichi Sankyo, - (DSNKY) Japan $39.630B 19.74
BeOne Medicines - (ONC) Switzerland $37.087B 196.62
Sandoz Group AG (SDZNY) Switzerland $33.939B 0.00
United Therapeutics (UTHR) United States $20.018B 17.62
Merck (MKKGY) Germany $19.496B 12.02
Shionogi (SGIOY) Japan $15.261B 14.02
Neurocrine Biosciences (NBIX) United States $13.200B 31.67
Summit Therapeutics (SMMT) United States $13.140B 0.00
IPSEN (IPSEY) France $13.109B 0.00
Ionis Pharmaceuticals (IONS) United States $12.363B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.394B 0.00
Orion OYJ (ORINY) Finland $10.204B 29.15
Eisai (ESAIY) $8.236B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.576B 20.00
Stevanato Group S.p.A (STVN) Italy $5.981B 33.47
Crinetics Pharmaceuticals (CRNX) United States $5.313B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.613B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.216B 20.01
Indivior (INDV) United States $4.068B 16.60
Corcept Therapeutics (CORT) United States $3.653B 39.47
NewAmsterdam Pharma (NAMS) Netherlands $3.589B 0.00
Hypermarcas (HYPMY) Brazil $3.047B 20.91
Centessa Pharmaceuticals (CNTA) United Kingdom $2.984B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.790B 8.90
Ocular Therapeutix (OCUL) United States $2.401B 0.00
Dyne Therapeutics (DYN) United States $2.386B 0.00
Soleno Therapeutics (SLNO) United States $2.282B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.098B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.958B 23.20
Harrow (HROW) United States $1.774B 108.86
Guardian Pharmacy Services (GRDN) United States $1.712B 32.96
Ardelyx (ARDX) United States $1.640B 0.00
Oruka Therapeutics (ORKA) United States $1.617B 0.00
Enliven Therapeutics (ELVN) United States $1.585B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.570B 0.00
Collegium Pharmaceutical (COLL) United States $1.441B 7.14
BioCryst Pharmaceuticals (BCRX) United States $1.404B 83.25
Evotec AG (EVO) Germany $1.282B 0.00
Relay Therapeutics (RLAY) United States $1.274B 0.00
Xeris Biopharma Holdings (XERS) United States $1.248B 0.00
Savara (SVRA) United States $1.184B 0.00
ARS Pharmaceuticals (SPRY) United States $1.051B 0.00
Theravance Biopharma (TBPH) United States $1.014B 42.57
Cronos Group (CRON) Canada $0.967B 0.00
Xencor (XNCR) United States $0.913B 0.00
Nektar Therapeutics (NKTR) United States $0.766B 0.00
KalVista Pharmaceuticals (KALV) United States $0.738B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.732B 17.31
Esperion Therapeutics (ESPR) United States $0.727B 0.00
ProKidney (PROK) United States $0.689B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.680B 6.07
Bioventus (BVS) United States $0.656B 13.44
Lexeo Therapeutics (LXEO) United States $0.539B 0.00
Elite Pharmaceuticals (ELTP) United States $0.506B 0.00
Lyell Immunopharma (LYEL) United States $0.505B 0.00
Zevra Therapeutics (ZVRA) United States $0.503B 0.00
Organogenesis (ORGO) United States $0.481B 0.00
Siga Technologies (SIGA) United States $0.471B 6.45
Altimmune (ALT) United States $0.442B 0.00
4D Molecular Therapeutics (FDMT) United States $0.431B 0.00
Nature's Sunshine Products (NATR) United States $0.421B 25.07
Aquestive Therapeutics (AQST) United States $0.404B 0.00
USANA Health Sciences (USNA) United States $0.401B 11.19
Akebia Therapeutics (AKBA) United States $0.361B 0.00
Achieve Life Sciences (ACHV) Canada $0.310B 0.00
Profound Medical (PROF) Canada $0.298B 0.00
Aclaris Therapeutics (ACRS) United States $0.284B 0.00
Avalo Therapeutics (AVTX) United States $0.279B 0.00
Aldeyra Therapeutics (ALDX) United States $0.279B 0.00
Relmada Therapeutics (RLMD) United States $0.274B 0.00
OmniAb (OABI) United States $0.274B 0.00
Heron Therapeutics (HRTX) United States $0.273B 0.00
Fractyl Health (GUTS) United States $0.262B 0.00
Larimar Therapeutics (LRMR) United States $0.259B 0.00
Protara Therapeutics (TARA) United States $0.259B 0.00
Silence Therapeutics (SLN) United Kingdom $0.238B 0.00
Enlivex Therapeutics (ENLV) Israel $0.223B 0.00
Journey Medical (DERM) United States $0.217B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.209B 0.00
Galectin Therapeutics (GALT) United States $0.196B 0.00
Minerva Neurosciences (NERV) United States $0.193B 0.00
Century Therapeutics (IPSC) United States $0.190B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
MediWound (MDWD) Israel $0.180B 0.00
Surrozen (SRZN) United States $0.171B 0.00
AleAnna (ANNA) United States $0.171B 0.00
VAXART, INC (VXRT) United States $0.169B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.161B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.146B 0.00
Unicycive Therapeutics (UNCY) United States $0.133B 0.00
Context Therapeutics (CNTX) United States $0.132B 0.00
Incannex Healthcare (IXHL) Australia $0.131B 0.00
Inhibikase Therapeutics (IKT) United States $0.126B 0.00
Avita Medical (RCEL) United States $0.119B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.116B 0.00
Karyopharm Therapeutics (KPTI) United States $0.116B 0.00
Prelude Therapeutics (PRLD) United States $0.114B 0.00
Pyxis Oncology (PYXS) United States $0.110B 0.00
Cardiol Therapeutics (CRDL) Canada $0.105B 0.00
Champions Oncology (CSBR) United States $0.100B 42.41
Cassava Sciences (SAVA) United States $0.099B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Korro Bio (KRRO) United States $0.083B 0.00
Assertio Holdings (ASRT) United States $0.074B 0.00
Gain Therapeutics (GANX) United States $0.070B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.070B 58.13
PolyPid (PYPD) Israel $0.069B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
NRx Pharmaceuticals (NRXP) United States $0.067B 0.00
Arch Biopartners (ACHFF) Canada $0.066B 0.00
Rafael Holdings (RFL) United States $0.064B 0.00
Acrivon Therapeutics (ACRV) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Lipocine (LPCN) United States $0.062B 0.00
PMV Pharmaceuticals (PMVP) United States $0.060B 0.00
ElectroCore (ECOR) United States $0.057B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Lite Strategy (LITS) United States $0.053B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Talphera (TLPH) United States $0.047B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
Plus Therapeutics (PSTV) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Kyntra Bio Inc (KYNB) United States $0.037B 0.00
Wellgistics Health (WGRX) United States $0.036B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.030B 0.00
Jupiter Neurosciences (JUNS) United States $0.030B 0.00
Natural Alternatives (NAII) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.026B 0.00
Klotho Neurosciences (KLTO) United States $0.024B 0.00
Scienture Holdings (SCNX) United States $0.022B 0.00
Liminatus Pharma (LIMN) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.020B 0.00
Inotiv (NOTV) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.016B 0.02
Vyome Holdings (HIND) United States $0.016B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Ainos (AIMD) United States $0.009B 0.00
BioVie (BIVI) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Decoy Therapeutics Inc (DCOY) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Lyra Therapeutics (LYRA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.003B 0.00
CDT Equity (CDT) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00